Department of Radiology (M.L., M.D.L., B.C.Y., D.P.M., E.J.F., S.P.R., W.A.M., J.C., S.Y.H., J.K.-C., B.P.L., K.B.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Department of Radiology (M.L., M.D.L., B.C.Y., D.P.M., E.J.F., S.P.R., W.A.M., J.C., S.Y.H., J.K.-C., B.P.L., K.B.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
AJNR Am J Neuroradiol. 2021 May;42(5):831-837. doi: 10.3174/ajnr.A7032. Epub 2021 Feb 4.
Severe respiratory distress in patients with COVID-19 has been associated with higher rate of neurologic manifestations. Our aim was to investigate whether the severity of chest imaging findings among patients with coronavirus disease 2019 (COVID-19) correlates with the risk of acute neuroimaging findings.
This retrospective study included all patients with COVID-19 who received care at our hospital between March 3, 2020, and May 6, 2020, and underwent chest imaging within 10 days of neuroimaging. Chest radiographs were assessed using a previously validated automated neural network algorithm for COVID-19 (Pulmonary X-ray Severity score). Chest CTs were graded using a Chest CT Severity scoring system based on involvement of each lobe. Associations between chest imaging severity scores and acute neuroimaging findings were assessed using multivariable logistic regression.
Twenty-four of 93 patients (26%) included in the study had positive acute neuroimaging findings, including intracranial hemorrhage ( = 7), infarction ( = 7), leukoencephalopathy ( = 6), or a combination of findings ( = 4). The average length of hospitalization, prevalence of intensive care unit admission, and proportion of patients requiring intubation were significantly greater in patients with acute neuroimaging findings than in patients without them ( < .05 for all). Compared with patients without acute neuroimaging findings, patients with acute neuroimaging findings had significantly higher mean Pulmonary X-ray Severity scores (5.0 [SD, 2.9] versus 9.2 [SD, 3.4], < .001) and mean Chest CT Severity scores (9.0 [SD, 5.1] versus 12.1 [SD, 5.0], = .041). The pulmonary x-ray severity score was a significant predictor of acute neuroimaging findings in patients with COVID-19.
Patients with COVID-19 and acute neuroimaging findings had more severe findings on chest imaging on both radiographs and CT compared with patients with COVID-19 without acute neuroimaging findings. The severity of findings on chest radiography was a strong predictor of acute neuroimaging findings in patients with COVID-19.
COVID-19 患者严重呼吸窘迫与更高的神经系统表现发生率相关。我们的目的是研究 2019 冠状病毒病(COVID-19)患者的胸部影像学表现严重程度是否与急性影像学发现的风险相关。
本回顾性研究纳入了 2020 年 3 月 3 日至 2020 年 5 月 6 日期间在我院接受治疗的所有 COVID-19 患者,且在神经影像学检查后 10 天内行胸部影像学检查。使用先前验证的 COVID-19 自动神经网络算法(Pulmonary X-ray Severity score)评估胸部 X 线片。使用基于每个肺叶受累的 Chest CT Severity 评分系统对胸部 CT 进行分级。使用多变量逻辑回归评估胸部影像学严重程度评分与急性神经影像学发现之间的关系。
研究共纳入 93 例患者,其中 24 例(26%)患者的急性神经影像学检查结果为阳性,包括颅内出血( = 7)、梗死( = 7)、脑白质病( = 6)或上述多种表现同时存在( = 4)。与无急性神经影像学发现的患者相比,有急性神经影像学发现的患者的平均住院时间更长、入住重症监护病房的比例更高、需要插管的比例也更高(所有 <.05)。与无急性神经影像学发现的患者相比,有急性神经影像学发现的患者的平均 Pulmonary X-ray Severity score 更高[5.0(标准差[SD],2.9)比 9.2(SD,3.4), <.001],平均 Chest CT Severity score 也更高[9.0(SD,5.1)比 12.1(SD,5.0), =.041]。在 COVID-19 患者中,肺部 X 射线严重程度评分是急性神经影像学发现的显著预测因素。
与 COVID-19 患者中无急性神经影像学发现的患者相比,COVID-19 伴有急性神经影像学发现的患者的胸部影像学检查,无论是 X 线片还是 CT,其严重程度均更高。胸部 X 线片的严重程度是 COVID-19 患者急性神经影像学发现的一个强有力的预测因素。